Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


It's time for pharma to change its ways on transparency

This article was originally published in SRA

Executive Summary

Transparency is an unstoppable tide and the industry should embrace it rather than fight against it, says Ben Goldacre.

You may also be interested in...

COMMENT: 'Bad Pharma' gets a scolding from Goldacre

Criticizing the pharmaceutical industry, I've recently discovered, is a little like questioning a cult: there are outlandish smears, lurid denunciations, and implausible outright denials. People within the community award themselves a point for this behavior, while outsiders look on in amazement. I’d like to speak with those of you who are able to step outside of this game.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts